PALISADE BIO, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Palisade Bio, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Palisade Bio, Inc. Return On Equity for the quarter ending September 30, 2024 was -148 %, a 59.4% decline year-over-year.
  • Palisade Bio, Inc. annual Return On Equity for 2023 was -89.6 %, a 46.8% increase from 2022.
  • Palisade Bio, Inc. annual Return On Equity for 2022 was -168 %, a 129% decline from 2021.
  • Palisade Bio, Inc. annual Return On Equity for 2021 was 584 %, a 627% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -148 -55.3 -59.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -125 -26.1 -26.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -105 +10.4 +9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -89.6 +78.7 +46.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -93 +38.5 +29.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -98.8 -150 -292% Apr 1, 2023 Jun 30, 2023
Q1 2023 -116 +1.5K +92.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -168 -752 -129% Oct 1, 2022 Dec 31, 2022
Q3 2022 -132 -434 -143% Jul 1, 2022 Sep 30, 2022
Q2 2022 51.5 -233 -81.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.62K -1.69K -2165% Jan 1, 2022 Mar 31, 2022
Q4 2021 584 +504 +627% Oct 1, 2021 Dec 31, 2021
Q3 2021 303 +227 +302% Jul 1, 2021 Sep 30, 2021
Q2 2021 284 +145 +105% Apr 1, 2021 Jun 30, 2021
Q1 2021 78.2 -241 -75.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 80.4 +927 Oct 1, 2020 Dec 31, 2020
Q3 2020 75.3 +220 Jul 1, 2020 Sep 30, 2020
Q2 2020 139 +309 Apr 1, 2020 Jun 30, 2020
Q1 2020 319 +437 Jan 1, 2020 Mar 31, 2020
Q4 2019 -847 -762 -902% Oct 1, 2019 Dec 31, 2019
Q3 2019 -145 -21.9 -17.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -170 -94.3 -124% Apr 1, 2019 Jun 30, 2019
Q1 2019 -118 +1.23 +1.03% Jan 1, 2019 Mar 31, 2019
Q4 2018 -84.5 +82.4 +49.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -123 +52.9 +30.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -75.8 +289 +79.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -119 +366 +75.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -167 +860 +83.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -176 +4.25K +96% Jul 1, 2017 Sep 30, 2017
Q2 2017 -365 +209 +36.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -485 -167 -52.6% Jan 1, 2017 Mar 31, 2017
Q4 2016 -1.03K -851 -486% Oct 1, 2016 Dec 31, 2016
Q3 2016 -4.42K -4.28K -2991% Jul 1, 2016 Sep 30, 2016
Q2 2016 -574 -461 -409% Apr 1, 2016 Jun 30, 2016
Q1 2016 -318 -212 -200% Jan 1, 2016 Mar 31, 2016
Q4 2015 -175 -74 -73.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -143 -41.2 -40.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -113 +21.2 +15.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -106 +78.6 +42.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -101 +195 +65.9% Oct 1, 2014 Dec 31, 2014
Q3 2014 -102 +202 +66.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -134 +97.2 +42% Apr 1, 2014 Jun 30, 2014
Q1 2014 -185 +0.99 +0.53% Jan 1, 2014 Mar 31, 2014
Q4 2013 -296 -121 -68.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -304 -79.6 -35.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -231 +106 +31.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -186 +104 +36% Jan 1, 2013 Mar 31, 2013
Q4 2012 -175 Oct 1, 2012 Dec 31, 2012
Q3 2012 -224 Jul 1, 2012 Sep 30, 2012
Q2 2012 -337 Apr 1, 2012 Jun 30, 2012
Q1 2012 -290 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.